Abstract: Objective: To evaluate the antioxidation of dihydrobiopterin reductase and to explore the effect of A278C mutation of the quinoid dihydropteridine reductase (QDPR) gene on its antioxidant activity. Methods: First, plasmids with different genes (wild and mutant QDPR) were constructed. After gene sequencing, they were transfected into human kidney cells (HEK293T). Then, the intracellular production of reactive oxygen species (ROS) and tetrahydrobiopterin (BH4) was detected after cells were harvested. Activations of nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4), glutathione peroxidase 3 (GPX3), and superoxide dismutase 1 (SOD1) were analyzed to observe the oxidative stress after transfection. The expression of the neuronal nitric oxide synthase (nNOS) gene was analyzed by semiquantitative reverse-transcription polymerase chain reaction (RT-PCR). We also detected the activation of transforming growth factor β1 (TGF-β1) by enzyme-linked immunosorbent assay (ELISA) to observe the connection of TGF-β1 and oxidative stress. Results: The exogenous wild-type QDPR significantly decreased the expression of nNOS, NOX4, and TGF-β1 and induced the expression of SOD1 and GPX3, but the mutated QDPR lost this function and resulted in excessive ROS production. Our data also suggested that the influence on the level of BH4 had no significant difference between mutated and the wild-type QDPR transfection. Conclusions: Wild-type QDPR played an important role in protecting against oxidative stress, but mutant QDPR failed to have these beneficial effects.

A278C位点突变减弱了二氢生物蝶呤还原酶的抗氧化作用

[1]Bhattacharjee, N., Barma, S., Konwar, N., et al., 2016. Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update. Eur. J. Pharmacol., 791:8-24.

[2]Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865):813-820.

[3]Delgado-Esteban, M., Almeida, A., Medina, J.M., 2002. Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia. J. Neurochem., 82(5):1148-1159.

[4]Dobashi, K., Asayama, K., Hayashibe, H., et al., 1991. Effect of diabetes mellitus induced by streptozotocin on renal superoxide dismutases in the rat. A radioimmunoassay and immunohistochemical study. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 60(1):67-72.

[5]Feng, B., Yan, X.F., Xue, J.L., et al., 2013. The protective effects of α-lipoic acid on kidneys in type 2 diabetic Goto-Kakisaki rats via reducing oxidative stress. Int. J. Mol. Sci., 14(4):6746-6756.

[6]Gu, Y., Gong, Y., Zhang, H., et al., 2013. Regulation of transforming growth factor β1 gene expression by dihydropteridine reductase in kidney 293T cells. Biochem. Cell Biol., 91(3):187-193.

[7]Horie, K., Miyata, T., Maeda, K., et al., 1997. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin. Invest., 100(12):2995-3004.

[8]Kim, J.A., Montagnani, M., Koh, K.K., et al., 2006. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation, 113(15):1888-1904.

[9]Möllsten, A., Lajer, M., Jorsal, A., et al., 2009. The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes. Mol. Genet. Metab., 97(1):80-84.

[10]Newsholme, P., Gaudel, C., Krause, M., 2012. Mitochondria and diabetes. An intriguing pathogenetic role. In: Scatena, R., Bottoni, P., Giardina, B. (Eds.), Advances in Mitochondrial Medicine. Advances in Experimental Medicine and Biology, Vol. 942. Springer Netherlands, p.235-247.

[11]Oliveira, H.R., Verlengia, R., Carvalho, C.R., et al., 2003. Pancreatic β-cells express phagocyte-like NAD(P)H oxidase. Diabetes, 52(6):1457-1463.

[12]Ong, H.B., Sienkiewicz, N., Wyllie, S., et al., 2011. Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major. J. Biol. Chem., 286(12):10429-10438.

[13]Pan, H.Z., Zhang, L., Guo, M.Y., et al., 2010. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol., 47(S1):71-76.

[14]Satoh, M., Fujimoto, S., Arakawa, S., et al., 2008. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol. Dial. Transplant., 23(12):3806-3813.

[15]Schnackenberg, C.G., Wilcox, C.S., 2001. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int., 59(5):1859-1864.

[16]Shah, A., Xia, L., Goldberg, H., et al., 2013. Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J. Biol. Chem., 288(10):6835-6848.

[17]Sharma, A.K., Bharti, S., Kumar, R., et al., 2012. Syzygium cumini ameliorates insulin resistance and β-cell dysfunction via modulation of PPARγ, dyslipidemia, oxidative stress, and TNF-α in type 2 diabetic rats. J. Pharmacol. Sci., 119(3):205-213.

[18]Si, Q., Sun, S.F., Gu, Y.T., 2017. A278C mutation of dihydropteridine reductase decreases autophagy via mTOR signaling. Acta Biochim. Biophys. Sin., 49(8):706-712.

[19]Thöny, B., Auerbach, G., Blau, N., 2000. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem. J., 347(1):1-16.

[20]Uchizono, Y., Takeya, R., Iwase, M., et al., 2006. Expression of isoforms of NADPH oxidase components in rat pancreatic islets. Life Sci., 80(2):133-139.

[21]Ugolino, J., Ji, Y.J., Conchina, K., et al., 2016. Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling. PLoS Genet., 12(11):e1006443.

[22]Wang, X., Ke, Z., Chen, G., et al., 2012. Cdc42-dependent activation of NADPH oxidase is involved in ethanol-induced neuronal oxidative stress. PLoS ONE, 7(5):e38075.

[23]Yu, H.T., Zhen, J., Pang, B., et al., 2015. Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats. J. Zhejiang Univ. -Sci. B (Biomed. & Biotechnol.), 16(5):344-354.

[24]Zeng, G., Nystrom, F.H., Ravichandran, L.V., et al., 2000. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation, 101(13):1539-1545.